Literature DB >> 11149754

Violacein cytotoxicity and induction of apoptosis in V79 cells.

P S Melo1, S S Maria, B C Vidal, M Haun, N Durán.   

Abstract

Violacein, a pigment produced by Chromobacterium violaceum, is reported to be a potential drug for the treatment of Chagas' disease. Violacein is also effective against leukemia and lymphoma cells in culture (IC50 10(-8) M). Changes in the nuclear acid content, 3-(4,5-dimethylthiazole-2-yl)-2,5-biphenyl tetrazolium bromide reduction and neutral red uptake in these cells were used to evaluate the cytotoxicity of violacein in V79 Chinese hamster (M-8) fibroblasts. Violacein was highly cytotoxic to V79 fibroblasts (IC50 5-12 microM). Using the TUNEL method and the Feulgen reaction coupled to image analysis, violacein (5 and 10 microM) was found to trigger apoptosis but not necrosis in V79 cells. The morphological changes seen in the nuclei of these cells included chromatin condensation and a decrease in deoxyribonucleic acid content. These results demonstrating that violacein induces apoptosis in V79 cells strengthen its potential as a therapeutic agent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11149754     DOI: 10.1290/1071-2690(2000)036<0539:vcaioa>2.0.co;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  19 in total

1.  Evaluation of membrane physiology following fluorescence activated or magnetic cell separation.

Authors:  J Seidl; R Knuechel; L A Kunz-Schughart
Journal:  Cytometry       Date:  1999-06-01

2.  Vitality measurement using spectrum shift in Hoechst 33342 stained cells.

Authors:  J W Ellwart; P Dörmer
Journal:  Cytometry       Date:  1990

3.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Chromatin changes in apoptosis.

Authors:  A H Wyllie; G J Beattie; A D Hargreaves
Journal:  Histochem J       Date:  1981-07

6.  Choice and standardization of test protocols in cytotoxicology: A multicentre approach.

Authors:  M R Cingi; I De Angelis; E Fortunati; D Reggiani; V Bianchi; R Tiozzo; F Zucco
Journal:  Toxicol In Vitro       Date:  1991       Impact factor: 3.500

7.  EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models.

Authors:  H R Hendriks; P E Pizao; D P Berger; K L Kooistra; M C Bibby; E Boven; H C Dreef-van der Meulen; R E Henrar; H H Fiebig; J A Double
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

8.  An evaluation of three in vitro cytotoxicity assays.

Authors:  R J Riddell; R H Clothier; M Balls
Journal:  Food Chem Toxicol       Date:  1986 Jun-Jul       Impact factor: 6.023

9.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

Authors:  F Denizot; R Lang
Journal:  J Immunol Methods       Date:  1986-05-22       Impact factor: 2.303

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  19 in total

1.  The violacein biosynthetic enzyme VioE shares a fold with lipoprotein transporter proteins.

Authors:  Katherine S Ryan; Carl J Balibar; Kaitlyn E Turo; Christopher T Walsh; Catherine L Drennan
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

Review 2.  Therapeutic applications of bacterial pigments: a review of current status and future opportunities.

Authors:  Muhammad Numan; Samina Bashir; Roqayya Mumtaz; Sibgha Tayyab; Najeeb Ur Rehman; Abdul Latif Khan; Zabta Khan Shinwari; Ahmed Al-Harrasi
Journal:  3 Biotech       Date:  2018-04-04       Impact factor: 2.406

3.  Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Claira Arul Aruldass; Santhana Raj Louis Masalamany; Chidambaram Kulandaisamy Venil; Wan Azlina Ahmad
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-31       Impact factor: 4.223

4.  Efflux Pumps in Chromobacterium Species Increase Antibiotic Resistance and Promote Survival in a Coculture Competition Model.

Authors:  Saida Benomar; Kara C Evans; Robert L Unckless; Josephine R Chandler
Journal:  Appl Environ Microbiol       Date:  2019-09-17       Impact factor: 4.792

5.  Diversity in antifungal activity of strains of Chromobacterium violaceum from the Brazilian Amazon.

Authors:  Eriana Serpa Barreto; Adalgisa Ribeiro Torres; Marliton Rocha Barreto; Ana Tereza Ribeiro Vasconcelos; Spartaco Astolfi-Filho; Mariangela Hungria
Journal:  J Ind Microbiol Biotechnol       Date:  2008-03-18       Impact factor: 3.346

6.  Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo.

Authors:  Stefanie C P Lopes; Yara C Blanco; Giselle Z Justo; Paulo A Nogueira; Francisco L S Rodrigues; Uta Goelnitz; Gerhard Wunderlich; Gustavo Facchini; Marcelo Brocchi; Nelson Duran; Fabio T M Costa
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

7.  The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability.

Authors: 
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-18       Impact factor: 11.205

8.  Violacein induces death of RAS-mutated metastatic melanoma by impairing autophagy process.

Authors:  Paola R Gonçalves; Karin J P Rocha-Brito; Maruska R N Fernandes; Julia L Abrantes; Nelson Durán; Carmen V Ferreira-Halder
Journal:  Tumour Biol       Date:  2016-08-08

9.  Isolation and characterization of two groups of novel marine bacteria producing violacein.

Authors:  Shuichi Yada; Yi Wang; Yanshuang Zou; Keiko Nagasaki; Kakushi Hosokawa; Issey Osaka; Ryuichi Arakawa; Keiich Enomoto
Journal:  Mar Biotechnol (NY)       Date:  2007-10-30       Impact factor: 3.619

10.  Biogenic Aspergillus tubingensis silver nanoparticles' in vitro effects on human umbilical vein endothelial cells, normal human fibroblasts, HEPG2, and Galleria mellonella.

Authors:  Cristiane Angélica Ottoni; Durvanei Augusto Maria; Priscila Jane Romano de Oliveira Gonçalves; Welington Luiz de Araújo; Ana Olívia de Souza
Journal:  Toxicol Res (Camb)       Date:  2019-10-10       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.